BioReference will offer COVID-19 testing for public drive-through facilities for Miami residents and Larkin Community Hospital ELMWOOD PARK, N.J., March 24, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Miami to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations […]
Search Results for: care
Press Release
OPKO Health’s BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19)
23
Mar
Mar
BioReference will offer COVID-19 testing for public drive-through facilities for Detroit residents ELMWOOD PARK, N.J., March 23, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Detroit to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations for Detroit residents by appointment. “The impact that expanded testing will […]
Press Release
OPKO Health’s BioReference Laboratories and State of New Jersey Provide Testing for Coronavirus Disease 2019 (COVID-19)
20
Mar
Mar
BioReference offers COVID-19 testing for first five NJ drive-through testing facilities in the counties of Burlington, Essex, Hudson, Ocean and Union BioReference to participate in NJ press conference on Friday, March 20 at 2:00 p.m. ET ELMWOOD PARK, N.J., March 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration […]
Press Release
OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19)
17
Mar
Mar
OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19) BioReference Laboratories commits to testing 5,000 New Yorkers each day ELMWOOD PARK, N.J., March 17, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the New York City […]
South Florida Business Journal BioReference Laboratories, a subsidiary of Miami-based Opko Health (Nasdaq: OPK), has begun accepting specimen from health care providers throughout the U.S. to test whether or not their patients have COVID-19. The lab launched testing Friday, expecting to start with about 1,000 to 2,000 tests a day. BioReference expects to eventually ramp […]
Press Release
OPKO Health’s BioReference Laboratories Offers Testing for Coronavirus Disease 2019 (COVID-19)
13
Mar
Mar
In partnership with NY State Department of Health, BioReference will provide COVID-19 testing for the first public drive-through testing facility on the East Coast COVID-19 tests now available for use by healthcare providers throughout the US ELMWOOD PARK, N.J., March 13, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), is now […]
Press Release
OPKO Health’s BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test
05
Mar
Mar
COVID-19 test will aid healthcare professionals and public health authorities to identify patients infected with COVID-19 ELMWOOD PARK, N.J., March 05, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it will offer a test for the novel coronavirus (2019-nCoV), a contagious virus that causes respiratory infection and has shown evidence of human-to-human […]
ACLA Statement on COVID-19 Testing STATEMENT FROM ACLA PRESIDENT JULIE KHANI: “We appreciated the opportunity to meet with Vice President Pence and members of the White House’s Coronavirus Task Force this afternoon on the critical issues related to testing capacity. As an industry, clinical labs have taken steps to meet the growing demand for national […]
